| Basic data
|
| (11) | Registration Number: | P20120104 (Validated european patent) | |
| (21) | File number: | P20120104T |
| (22) | Date of filing the request: | 01.02.2012 |
| (54) | English Title: | DIOXA-BICYCLO[3.2.1.]OCTANE-2,3,4-TRIOL DERIVATIVES | |
| (51) | IPC: | C07D 493/10 (2006.01) |
| | | C07H 15/18 (2006.01) |
| | | A61K 31/357 (2006.01) |
| | | A61P 3/10 (2006.01) |
| (73) | Holder(s): | | 1. | Pfizer Inc., 66 Hudson Boulevard East, New York, NY 10001-2192, US |
| |
| (72) | Inventor(s): | | 1. | Vincent Mascitti, Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340, US |
| |
| | | 2. | Benjamin Micah Collman, Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340, US |
| |
| (74) | Representative: | Hraste & Partneri odvjetničko društvo d.o.o.,
Ribnjak 40, 10000 Zagreb, HR
|
| (30) | Priority Data: | | (31) | 227212 P | | (32) | 21.07.2009 | | (33) | US | | | 92470 P | | | 28.08.2008 | | | US |
|
| (86) | PCT Application Number and Date: | PCT/IB2009053626; 17.08.2009 |
| (87) | PCT Publication Number and Date: | WO2010023594; 04.03.2010 |
| (96) | Number of the European patent application: | EP 09786960.6, 17.08.2009 | |
| (97) | Publication data of the European patent: | EP 2334687, 04.01.2012, en | |
| (46) | Publication Date of Translation of a European Patent Claims and the Gazette Number: | 29.02.2012, HGIV 2/2012 |
| | Annual fee: | 16.07.2025 for the 17th year | |
|
| | SPC | |
| (21) | Request Number: | S20180013A |
| (22) | Filing Date: | 27.08.2018 |
| (11) | SPC Number | S20180013 |
| (73) | Holder(s) | | 1. | Pfizer Inc., 66 Hudson Boulevard East, New York, NY 10001-2192, US |
|
| (95) | Product Name: | ERTUGLIFLOZIN, OPCIONALNO KAO KRISTALNI OBLIK, OSOBITO KAO SUKRISTAL S L-PIROGLUTAMINSKOM KISELINOM, A SPECIFIČNO KAO ERTUGLIFLOZIN-L-PIROGLUTAMINSKA KISELINA |
| (43) | Request Publication Date: | 21.09.2018 |
| | | CHANGE OF NAME AND/OR ADDRESS | | New entry | Pfizer Inc.,
66 Hudson Boulevard East, New York, NY 10001-2192, US
| | Previous entry | Pfizer Inc.,
235 East 42nd Street, New York, NY 10017, US
| | Recording date | 04.04.2023 | | Publication date | 28.04.2023 | |
|